BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29068867)

  • 1. Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.
    Mosakhani N; Missiry ME; Vakkila E; Knuutila S; Vakkila J
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):585-588. PubMed ID: 29068867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
    Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
    Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
    Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
    Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia.
    Nabhan M; Louka ML; Khairy E; Tash F; Ali-Labib R; El-Habashy S
    Gene; 2017 Sep; 628():253-258. PubMed ID: 28732737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
    Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
    Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
    Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression and regulatory mechanism of microRNA-708 in pediatric common B-cell acute lymphoblastic leukemia].
    Li X; Li D; Zhuang Y; Shi Q; Wei W; Zhang H; Ju XL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):138-43. PubMed ID: 23611221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia.
    Duyu M; Durmaz B; Gunduz C; Vergin C; Yilmaz Karapinar D; Aksoylar S; Kavakli K; Cetingul N; Irken G; Yaman Y; Ozkinay F; Cogulu O
    Biomed Res Int; 2014; 2014():967585. PubMed ID: 24955371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
    Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression and clinical significance of miR-203 in pediatric acute leukemia].
    Wang N; Pan J; Cao L; Lu J; Xiao PF; Zhao WL; Hu SY; Chai YH
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):777-81. PubMed ID: 24103876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells and regulatory T cells share common immunoregulatory pathways-related microRNAs that are dysregulated by acute lymphoblastic leukemia and chemotherapy.
    Labib Salem M; Zidan AA; Ezz El-Din El-Naggar R; Attia Saad M; El-Shanshory M; Bakry U; Zidan M
    Hum Immunol; 2021 Jan; 82(1):36-45. PubMed ID: 33162185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia.
    Shafik RE; Abd El Wahab N; Mokhtar MM; El Taweel MA; Ebeid E
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3429-3434. PubMed ID: 33247705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Valiollahi E; Ribera JM; Genescà E; Behravan J
    Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.
    Amankwah EK; Devidas M; Teachey DT; Rabin KR; Brown PA
    Anticancer Res; 2020 Jun; 40(6):3147-3153. PubMed ID: 32487609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
    Ghodousi ES; Rahgozar S
    J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
    Mesrian Tanha H; Mojtabavi Naeini M; Rahgozar S; Moafi A; Honardoost MA
    Tumour Biol; 2016 Jun; 37(6):7861-72. PubMed ID: 26700663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [microRNA expression in childhood acute granulocytic leukemia and its subtypes].
    Luo XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang LD
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):831-5. PubMed ID: 22335948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
    de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
    Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
    Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.